In keeping with the mission of the center, the MultiScan LFER150 PET/CT will help enable researchers to improve human and animal health by using noninvasive invivo imaging techniques to find better treatments for major infectious diseases. The MultiScan LFER 150 PET/CT is the only research-focused, large bore integrated PET/CT scanner supporting whole-body imaging of non-human primates (NHPs) and smaller animal models at sub-millimeter PET resolution. The system features the most versatile integrated PET/CT gantry ever built, enabling dynamic studies both in lying and sitting position, required for awake NHP studies. Due to its unique construction, CT and PET systems share the same field-of-view, eliminating the need for moving the subject during acquisition.

The LFER150 PET/CT will support TNPRC’s research program in infectious diseases, particularly in tuberculosis research focused on vaccine development, pathogenesis, and therapeutics.

“We have invested years to make the LFER150 PET/CT a dedicated and effective tool for imaging nonhuman primates for both PET and CT modalities. We are proud to be working with prestigious institutions like the TNPRC”, says Illes Muller, Managing Partner of Mediso USA. Like all preclinical PET/CT systems from Mediso, the LFER150 has been designed for quantitative assessment of PET and CT studies.

About Mediso USA, LLC

Mediso USA distributes the preclinical imaging portfolio of Mediso in the U.S. and Canada and provides the application development and technical support for life science research. The company’s headquarters is located in Boston, Massachusetts. For more information, please visit www.medisousa.com.

About Mediso Ltd.

Mediso Ltd. specializes in the field of nuclear and molecular imaging focused on the development, manufacturing, sales and servicing of multi-modality in-vivo imaging systems. It offers complete solutions from hardware design to quantification software, both for clinical patient care and high-level life science research. The nanoScan^® family is the first-line choice for preclinical imaging including the world’s first integrated preclinical PET/MRI, PET/CT, SPECT/CT and SPECT/MRI combinations.